Biotech distributor names may be prominently displayed on product packaging, labeling -- FDA proposal.
BIOTECH DISTRIBUTOR NAMES MAY BE PROMINENTLY DISPLAYED ON PRODUCT PACKAGES, eliminating the FDA rule that manufacturers names be more prominent, according to an agency proposed rule published in the Sept. 27 Federal Register. FDA said it plans to amend the biologics labeling regulations "to remove the requirement that the manufacturer's name be more prominent than the distributor and to permit the names of distributors to be prominently displayed on biological product container labels, package labels and labeling."
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth